TABLE 01. COMPLETED CLINICAL TRIALS IN BIOPHARMACEUTICALS MARKET
TABLE 02. GLOBAL BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 03. KEY MONOCLONAL ANTIBODIES
TABLE 04. MONOCLONAL ANTIBODIES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 05. INTERFERONS BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. INSULIN BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 07. GROWTH AND COAGULATION FACTORS BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 08. ERYTHROPOIETIN BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 09. VACCINES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 10. HORMONES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 11. OTHER BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 13. CANCER: KEY BIOPHARMACEUTICALS
TABLE 14. ONCOLOGY BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 15. BLOOD DISORDERS: KEY BIOPHARMACEUTICALS
TABLE 16. BLOOD DISORDERS BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 17. METABOLIC DISEASES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 18. INFECTIOUS DISEASES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 19. CARDIOVASCULAR DISEASES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 20. NEUROLOGICAL DISEASES BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 21. IMMUNOLOGY BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 22. OTHER APPLICATIONS BIOPHARMACEUTICALS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 23. BIOPHARMACEUTICALS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 24. NORTH AMERICA BIOPHARMACEUTICALS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 25. U.S. BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 26. U.S. BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 27. CANADA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 28. CANADA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 29. MEXICO BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 30. MEXICO BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 31. NORTH AMERICA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 32. NORTH AMERICA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 33. EUROPE BIOPHARMACEUTICALS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 34. GERMANY BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 35. GERMANY BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 36. FRANCE BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 37. FRANCE BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 38. UK BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 39. UK BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 40. ITALY BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 41. ITALY BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 42. SPAIN BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 43. SPAIN BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 44. REST OF EUROPE BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 45. REST OF EUROPE BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 46. EUROPE BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 47. EUROPE BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 48. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 49. JAPAN BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 50. JAPAN BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 51. CHINA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 52. CHINA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 53. INDIA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 54. INDIA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 55. AUSTRALIA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 56. AUSTRALIA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 57. SOUTH KOREA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 58. SOUTH KOREA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 59. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 60. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 61. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 62. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 63. LAMEA BIOPHARMACEUTICALS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 64. BRAZIL. BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 65. BRAZIL BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 66. SAUDI ARABIA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 67. SAUDI ARABIA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 68. SOUTH AFRICA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 69. SOUTH AFRICA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 70. REST OF LAMEA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 71. REST OF LAMEA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 72. LAMEA BIOPHARMACEUTICALS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 73. LAMEA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 74. ABBOTT: COMPANY SNAPSHOT
TABLE 75. ABBOTT: OPERATING SEGMENTS
TABLE 76. ABBOTT: PRODUCT PORTFOLIO
TABLE 77. AMGEN: COMPANY SNAPSHOT
TABLE 78. AMGEN: PRODUCT PORTFOLIO
TABLE 79. BIOGEN: COMPANY SNAPSHOT
TABLE 80. BIOGEN: PRODUCT PORTFOLIO
TABLE 81. LILLY: COMPANY SNAPSHOT
TABLE 82. LILLY: OPERATING SEGMENTS
TABLE 83. LILLY: PRODUCT PORTFOLIO
TABLE 84. ROCHE: COMPANY SNAPSHOT
TABLE 85. ROCHE: OPERATING SEGMENTS
TABLE 86. ROCHE: PRODUCT PORTFOLIO
TABLE 87. J&J: COMPANY SNAPSHOT
TABLE 88. J&J: OPERATING SEGMENTS
TABLE 89. J&J: PRODUCT PORTFOLIO
TABLE 90. MERCK: COMPANY SNAPSHOT
TABLE 91. MERCK: OPERATING SEGMENTS
TABLE 92. MERCK: PRODUCT PORTFOLIO
TABLE 93. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 94. NOVO NORDISK: OPERATING SEGMENTS
TABLE 95. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 96. PFIZER: COMPANY SNAPSHOT
TABLE 97. PFIZER: OPERATING SEGMENTS
TABLE 98. PFIZER: PRODUCT PORTFOLIO
TABLE 99. SANOFI: COMPANY SNAPSHOT
TABLE 100. SANOFI: OPERATING SEGMENTS
TABLE 101. SANOFI: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 01. BIOPHARMACEUTICALS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2014-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018*
FIGURE 06. MARKET SHARE ANALYSIS, 2017
FIGURE 07. PATENT REGISTERED/APPROVED, BY YEAR
FIGURE 08. PATENT REGISTERED, BY COUNTRY
FIGURE 09. BIOPHARMACEUTICALS MARKET: IMPACT ANALYSES
FIGURE 10. DIABETES BURDEN: KEY TAKEAWAYS
FIGURE 11. GLOBAL ELDERLY POPULATION (AGED 65 AND ABOVE), BY REGION (2015, 2030, AND 2050)
FIGURE 12. COMPARATIVE COUNTRY ANALYSIS OF MONOCLONAL ANTIBODIES BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 13. COMPARATIVE COUNTRY ANALYSIS OF INTERFERONS BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 14. COMPARATIVE COUNTRY ANALYSIS OF INSULIN BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 15. COMPARATIVE COUNTRY ANALYSIS OF GROWTH AND COAGULATION FACTORS BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 16. COMPARATIVE COUNTRY ANALYSIS OF ERYTHROPOIETIN BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 17. COMPARATIVE COUNTRY ANALYSIS OF VACCINES BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 18. COMPARATIVE COUNTRY ANALYSIS OF HORMONES BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 19. COMPARATIVE COUNTRY ANALYSIS OF OTHER BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 20. COMPARATIVE COUNTRY ANALYSIS OF ONCOLOGY BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 21. COMPARATIVE COUNTRY ANALYSIS OF BLOOD DISORDERS BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 22. COMPARATIVE COUNTRY ANALYSIS OF METABOLIC DISEASES BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 23. HEPATITIS: KEY FACTS
FIGURE 24. COMPARATIVE COUNTRY ANALYSIS OF INFECTIOUS DISEASES BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 25. COMPARATIVE COUNTRY ANALYSIS OF CARDIOVASCULAR DISEASES BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 26. COMPARATIVE COUNTRY ANALYSIS OF NEUROLOGICAL DISEASES BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 27. COMPARATIVE COUNTRY ANALYSIS OF IMMUNOLOGY BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 28. COMPARATIVE COUNTRY ANALYSIS OF OTHER APPLICATIONS BIOPHARMACEUTICALS MARKET, 2017 AND 2025 ($MILLION)
FIGURE 29. ABBOTT: NET SALES, 2015-2017 ($MILLION)
FIGURE 30. ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 31. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 32. AMGEN: NET SALES, 2015-2017 ($MILLION)
FIGURE 33. AMGEN: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 34. AMGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 35. BIOGEN: REVENUE, 2015-2017 ($MILLION)
FIGURE 36. BIOGEN: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 37. BIOGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 38. LILLY: NET SALES, 2015-2017 ($MILLION)
FIGURE 39. LILLY: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. LILLY: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 41. ROCHE: NET SALES, 2015-2017 ($MILLION)
FIGURE 42. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 43. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 44. J&J: NET SALES, 2015-2017 ($MILLION)
FIGURE 45. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 46. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 47. MERCK: NET SALES, 2015-2017 ($MILLION)
FIGURE 48. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 49. MERCK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 50. NOVO NORDISK: NET SALES, 2015-2017 ($MILLION)
FIGURE 51. NOVO NORDISK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 52. NOVO NORDISK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 53. PFIZER: NET SALES, 2015-2017 ($MILLION)
FIGURE 54. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 55. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 56. SANOFI: NET SALES, 2015-2017 ($MILLION)
FIGURE 57. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 58. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)